secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enovis CORP (ENOV)
CIK:        0001420800
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001420800-25-000038
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enovis Q3 sales up 9% to $549M; raises FY adjusted EBITDA and EPS guidance
--------------------------------------------------------------------------

- Q3 net sales $549M (+9% reported, +7% organic); Recon +12% reported, P&R +6% reported.
- Net loss $571M including $548M non-cash goodwill impairment; adjusted EPS $0.75.
- Divested Dr. Comfort (Diabetic Footcare) unit in Oct for up to $60M.
- Raised FY2025 guidance: revenue $2.24-2.27B, adj. EBITDA $395-405M, adj. EPS $3.10-3.25.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420800/000142080025000038/0001420800-25-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420800/000142080025000038/cfx-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001420800-25-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer